Company intelligence / Profile preview

SIS Medical

Frauenfeld, Thurgau, Switzerlandsis-medical.com ↗

Ownership: Private
Employees: ~30
Development stage: Other

Overview

SIS Medical has developed and commercialized a portfolio of high-performance PTCA balloon catheters for the treatment of challenging coronary lesions. Their flagship product OPN NC® Twin Wall Super High Pressure PTCA Balloon has received FDA approval and has been used in over 100,000 patients in Europe. The company continues to expand globally with recent registrations in Australia and plans for further market entries. Clinical results highlight the device’s ability to treat severely calcified or non-expandable lesions safely.

Therapeutic areas: Cardiovascular
Modalities: DeviceCatheter-based therapy (PTCA balloon catheters)
Industry: Surgical Medical Devices

Partnerships

Collaborates with heart centers/cardiology clinics globally

Beyond the preview

Go deeper on SIS Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIS Medical.

Explore the full profile